CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.-论文-万方医学网

第一作者： Quan,Zhou

第一单位： Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

作者： Quan,Zhou ^[1] ; Yangyang,Qi ^[2] ; Zewei,Wang ^[3] ; Han,Zeng ^[1] ; Hongyu,Zhang ^[1] ; Zhaopei,Liu ^[1] ; Qiuren,Huang ^[1] ; Ying,Xiong ^[3] ; Jiajun,Wang ^[3] ; Yuan,Chang ^[4] ; Qi,Bai ^[3] ; Yu,Xia ^[3] ; Yiwei,Wang ^[5] ; Li,Liu ^[3] ; Le,Xu ^[6] ; Bo,Dai ^[4] ; Jianming,Guo ^[3] ; Yu,Zhu ^[7] ; Weijuan,Zhang ^[8] ; Jiejie,Xu ^[9]

作者单位： Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China. ^[1] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. ^[2] Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. ^[3] Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. ^[4] Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[5] Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[6] Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China jjxufdu@fudan.edu.cn weijuanzhang@fudan.edu.cn yuzhu10@fudan.edu.cn. ^[7] Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China jjxufdu@fudan.edu.cn weijuanzhang@fudan.edu.cn yuzhu10@fudan.edu.cn. ^[8] Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China jjxufdu@fudan.edu.cn weijuanzhang@fudan.edu.cn yuzhu10@fudan.edu.cn. ^[9]

主题词老年人(Aged);动物(Animals);癌, 肾细胞(Carcinoma, Renal Cell);细胞系, 肿瘤(Cell Line, Tumor);化学疗法, 辅助(Chemotherapy, Adjuvant);DNA突变分析(DNA Mutational Analysis);疾病模型, 动物(Disease Models, Animal);无病生存(Disease-Free Survival);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤复发, 局部(Neoplasm Recurrence, Local);肾切除术(Nephrectomy);预后(Prognosis);受体, CCR5(Receptors, CCR5);肿瘤微环境(Tumor Microenvironment);肿瘤抑制蛋白质类(Tumor Suppressor Proteins);泛素硫酯酶(Ubiquitin Thiolesterase)

DOI 10.1136/jitc-2019-000228

PMID 32371459

发布时间 2021-05-26

检索历史清除

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

检索历史清除